Literature DB >> 22075794

Blastocystis: to treat or not to treat...

Christina M Coyle1, Julie Varughese, Louis M Weiss, Herbert B Tanowitz.   

Abstract

Parasites in the genus Blastocystis comprise several subtypes (genotypes) and have a worldwide distribution. In some surveys, these are the most common parasites found in human stool specimens. An emerging literature suggests that the pathogenicity of Blastocystis is related to specific subtypes and parasite burden, although even individuals with small numbers of cysts may be symptomatic. Some data suggest an association between infection with Blastocystis and irritable bowel syndrome. However, there are few clinical studies demonstrating a direct relationship between the presence of this parasite and disease, few animal models to explore this relationship, and no consensus as to appropriate treatment. We recommend that asymptomatic individuals with few cysts not be treated. However, those who have gastrointestinal or dermatologic signs and symptoms and many cysts in stool specimens may require treatment. Metronidazole is the drug of choice. Additional studies are required to determine pathogenicity and appropriate therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22075794     DOI: 10.1093/cid/cir810

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  48 in total

1.  Molecular detection of common intestinal parasites: a performance evaluation of the BD Max™ Enteric Parasite Panel.

Authors:  R Batra; E Judd; J Eling; W Newsholme; S D Goldenberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-07-09       Impact factor: 3.267

Review 2.  Understanding drug resistance in human intestinal protozoa.

Authors:  Hend Aly El-Taweel
Journal:  Parasitol Res       Date:  2015-03-19       Impact factor: 2.289

3.  Development and evaluation of high-resolution melting curve analysis for rapid detection and subtyping of Blastocystis and comparison the results with sequencing.

Authors:  Hanieh Mohammad Rahimi; Hamed Mirjalali; Maryam Niyyati; Ali Haghighi; Hamid Asadzadeh Aghdaei; Mohammad Reza Zali
Journal:  Parasitol Res       Date:  2019-11-05       Impact factor: 2.289

4.  Exacerbated symptoms in Blastocystis sp.-infected patients treated with metronidazole: two case studies.

Authors:  Arutchelvan Rajamanikam; Suresh Kumar; Chandramathi Samudi; Madhav Kudva
Journal:  Parasitol Res       Date:  2018-06-05       Impact factor: 2.289

5.  Comparison and Recommendations for Use of Dientamoeba fragilis Real-Time PCR Assays.

Authors:  Rory Gough; John Ellis; Damien Stark
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

6.  Identification of Blastocystis subtype 1 variants in the Home for Girls, Bangkok, Thailand.

Authors:  Umaporn Thathaisong; Suradej Siripattanapipong; Mathirut Mungthin; Duangnate Pipatsatitpong; Peerapan Tan-ariya; Tawee Naaglor; Saovanee Leelayoova
Journal:  Am J Trop Med Hyg       Date:  2012-11-19       Impact factor: 2.345

7.  Subtype determination of Blastocystis isolates by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS).

Authors:  D Martiny; A Bart; O Vandenberg; N Verhaar; E Wentink-Bonnema; C Moens; T van Gool
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-27       Impact factor: 3.267

8.  High prevalence of enteroparasitosis in urban slums of Belo Horizonte-Brazil. Presence of enteroparasites as a risk factor in the family group.

Authors:  Frederico F Gil; Haendel G N O Busatti; Valeria L Cruz; Joseph F G Santos; Maria A Gomes
Journal:  Pathog Glob Health       Date:  2013-08-01       Impact factor: 2.894

Review 9.  Promising Anti-Protozoan Activities of Propolis (Bee Glue) as Natural Product: A Review.

Authors:  Shabnam Asfaram; Mahdi Fakhar; Masoud Keighobadi; Javad Akhtari
Journal:  Acta Parasitol       Date:  2020-07-20       Impact factor: 1.440

Review 10.  Blastocystis, an unrecognized parasite: an overview of pathogenesis and diagnosis.

Authors:  Ivan Wawrzyniak; Philippe Poirier; Eric Viscogliosi; Meloni Dionigia; Catherine Texier; Frédéric Delbac; Hicham El Alaoui
Journal:  Ther Adv Infect Dis       Date:  2013-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.